Determination of leflunomide in tablets by high performance liquid chromatography

Yeniceli D., Dogrukol-Ak D., Tunçel M.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, sa.1, ss.197-201, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1016/j.jpba.2005.06.030
  • Dergi Adı: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.197-201
  • Anahtar Kelimeler: leflunomide, HPLC, tablet analysis, pharmaceuticals, HUMAN PLASMA, METABOLITE
  • Anadolu Üniversitesi Adresli: Evet

Özet

In the present study, a reverse phase high performance liquid chromatography (HPLC) method was validated and applied for the determination of leflunomide in tablets. Chromatographic separation of leflunomide and oxazepam as an internal standard was carried out on a C-18 column (50 mm, 3 mm i.d.) using a mobile phase, consisting of methanol and water (60:40, v/v), at a flow rate of 0.5 ml min(-1) and UV detection at 260 nm. The retention times for oxazepam and leflunomide were 2.6 and 5.2 min, respectively. The validated quantification range of the method was 2.7 x 10(-6) to 5.5 x 10(-5) M for leflunomide. The results of the developed procedure in tablets were compared with those of UV spectrophotometry to assess active leflunomide content. (c) 2005 Elsevier B.V. All rights reserved.